β2 -Microglobulin Levels in Patients with Postmenopausal Osteoporosis
The aim of this study was to evaluate the concentrations of b2 microglobulin in patients with postmenopausal osteoporosis and compare the results with the ones obtained from healthy postmenopausal women. We also evaluated the relationships between b2 microglobulin and bone mineral density (BMD), par...
Main Authors: | Funda Taşçıoğlu, Yıldıray Tabak, Pınar Ulaşan, Cengiz Öner |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2003-06-01
|
Series: | Türk Osteoporoz Dergisi |
Subjects: | |
Online Access: | http://www.turkosteoporozdergisi.org/article_4176/ve#9462-microglobulin-Levels-In-Patients-With-Postmenopausal-Osteoporosis |
Similar Items
-
Comprarison of Risendronate and Raloxifene Treatment in Postmenopausal Osteoporosis - Original Investigation
by: Dilek Koç Yılmaz, et al.
Published: (2006-09-01) -
The Effect of Continous or Intermittent Calcitonin in the Treatment of Postmenopausal Osteoporosis
by: F. Taşçıoğlu, et al.
Published: (2002-03-01) -
The Effect of Once-Weekly 70 Mg Alendronate Versus Once-Daily 10 Mg Alendronate in the Treatment of Postmenopausal Osteoporosis
by: İlker Çorapçı, et al.
Published: (2004-03-01) -
β2-microglobulin alters the profiles of inflammatory cytokines and of matrix metalloprotease in macrophages derived from the osteoarthritic synovium
by: Kyoko Muneshige, et al.
Published: (2023-01-01) -
The Effect of Alendronate and Calcitonin Treatments on Bone Mineral Density and Quality of Life in Women With Postmenopausal Osteoporosis
by: F. Taşçıoğlu, et al.
Published: (2002-06-01)